Christoph Driessen
University of St. Gallen(CH)University of St.Gallen(CH)Kantonsspital St. Gallen(CH)St. Gallen Oncology Conferences(CH)Ostschweizer Kinderspital(CH)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Peptidase Inhibition and Analysis, HIV/AIDS drug development and treatment
Most-Cited Works
- → Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4(2017)772 cited
- → Autophagy promotes MHC class II presentation of peptides from intracellular source proteins(2005)630 cited
- → Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events(2011)405 cited
- → Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer(2019)383 cited
- → Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study(2020)380 cited
- → Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)